Glioblastoma Clinical Trials in Boston, MA

Glioblastoma Clinical Trials in Boston, MA

View the best 10 glioblastoma medical studies in Boston, Massachusetts. Access promising new therapies by applying to a Boston-based Glioblastoma clinical trial.

Top rated glioblastoma clinical trials in Boston, Massachusetts

Here are the top 10 medical studies for glioblastoma in Boston, Massachusetts

Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide +2 More

Alkylating agents

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of UC Irvine Health Cancer Center-Newport in Costa Mesa, United States.

Olaparib

PARP Inhibitor

Recruiting1 awardPhase 2
This trial will study how well olaparib works in treating patients with certain types of cancer that have spread and usually cannot be controlled with treatment. Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Image of Massachusetts General Hospital in Boston, United States.

Personalized NeoAntigen Vaccine +1 More

Cancer Vaccine

Recruiting1 awardPhase 1
This trial is studying a new type of vaccine as a possible treatment for patients with glioblastoma. It is evaluating the safety of the vaccine and finding the right dose to use.
Image of Dana Farber Cancer Institute in Boston, United States.

rQNestin34.5v.2

Virus Therapy

Recruiting3 awardsPhase 1
This trial is testing the safety of a new virus-based drug for brain tumors. If it is safe, they will also test what dose is most effective.
Image of Children's Hospital Los Angeles in Los Angeles, United States.

BGB-290 +1 More

PARP Inhibitor

Recruiting1 awardPhase 1
This trial is testing the side effects and best dose of two drugs, BGB-290 and temozolomide, in treating adolescents and young adults with IDH1/2-mutant grade I-IV glioma.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing a new drug to see if it is safe and effective for people with different types of cancer.
Image of Illinois CancerCare-Bloomington in Bloomington, United States.

Atezolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing a combination of therapies to see if they're more effective than radiation therapy alone in treating recurrent glioblastoma.
Image of Saint Joseph's Hospital and Medical Center in Phoenix, United States.

Bevacizumab

Monoclonal Antibodies

Recruiting1 award
This trial uses DSC-MRI to measure rCBV to determine response to bevacizumab in patients with recurrent glioblastoma. DSC-MRI may help to evaluate changes in cancer blood vessels.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Ipilimumab +2 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2 & 3
This trial is testing whether adding immunotherapy to radiation therapy can help people with newly diagnosed glioblastoma that has an unmethylated MGMT.
Image of Hartford Healthcare (Data Collection) in Hartford, United States.

Nivolumab +1 More

Checkpoint Inhibitor

Recruiting1 awardPhase 2
This trial is testing if adding nivolumab to radiation therapy and bevacizumab improves treatment for recurrent glioblastoma.

Popular filter options for glioblastoma boston trials

Clinical Trials With No Placebo

View 53 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.